Development and test of the iValve. A new speech valve...

35
1/26 1/36 Development and test of the iValve. A new speech valve approach. EB (Ward) van der Houwen* T.A. van Kalkeren, J.G.M. Burgerhof, B.F.A.M. van der Laan and G.J. Verkerke BioMedical Engineering, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen. A. Deusinglaan 1, 9713AV, Groningen, [email protected]

Transcript of Development and test of the iValve. A new speech valve...

1/261/36

Development and test of the iValve. A new speech valve

approach.

EB (Ward) van der Houwen* T.A. van Kalkeren, J.G.M. Burgerhof, B.F.A.M. van der Laan and G.J. Verkerke

BioMedical Engineering, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen.

A. Deusinglaan 1, 9713AV, Groningen, [email protected]

2/262/36

University Medical Center Groningen

Groningen (GRQ): 187700 inhabitants. UMCG: 1339 Beds. >10000 employees

3/263/36

The laryngectomized patient

Removal of the larynx after cancer: breathing through a stoma.

4/264/36

reroute air through the pharynx for speech

reroute air through the pharynx for speech

5/265/36

Speaking laryngectomee

6/266/36

Tissue connector: EJO ten Hallers, EB van der Houwen, HAM Marres, GJ Verkerke

Adeva hands-free valve: AA Geertsema, GJ Verkerke

VPE: JW Tack, EB van der Houwen, GJ Verkerke

Groningen Button: Medin/Atos

EVPE: EB van der Houwen, BFAM van der Laan, GJ Verkerke

Speech restoration

iValve hands free inhalation valve

iPatch anatomically shaped stoma patch

Artificial Hyoid Bone: EB van der Houwen, IF Herrmann, GJ Verkerke

Dept of

BioMedical

Engineering

7/267/36

Use of patches and valvesLiterature

•78% of patients use stoma patches (Hilgers, 1991)

•70% of patients use a HME-filter (Bień, 2009)

•15-25% of Automatic Speech Valve use (Hilgers, 1991, Lorenz, 2007, Op de Coul, 2005)

•All studies show benefits of HME-use

Some clinical observations:

•Patients prefer hands-free speech

•ASV exert considerable stress on stoma patches

•Deepest stoma patches are ±7mm deep

•Most patients’ stomas are considerably deeper

Atos adhesive patch

Atos FreeHands ASV

HME-valve on patient

8/268/36

Existing Automatic speech valvesAdeva Window

InHealth hands-free valve

Atos FreeHands

Valve characteristics

•All based upon closing on exhalation

•Momentary speech mode only

•Patches release because of pressure

•Air lost at closure: short sentences

•Small speech dynamics

•Unnatural speech (no pauses)

•Learning curve

9/269/36

The iValve Automatic speech valve

Valve characteristics

•Based upon closing on inhalation

•Toggle switch to speech mode and back

•Lower pressure during speech

•No air lost at closure: long sentences

•Greater speech dynamics

•More natural speech (pauses allowed)

•Shorter learning curve

10/2610/36

The iValve Automatic speech valve

Valve characteristics

•Based upon closing on inhalation

•Toggle switch to speech mode and back

•Lower pressure during speech

•No air lost at closure: long sentences

•Greater speech dynamics

•More natural speech (pauses allowed)

•Shorter learning curve

Additional requirements

•Better speech quality

•Less parts than current

•Cheaper to manufacture

•Disposability

•Comfortable to skin

•Comparable size/weight

11/2611/36

Speaking with the iValve

12/2612/36

Overview

•iValve workings

•In vitro validation

•In vivo validation

•Conclusions and future development

13/2613/36

the iValve: three parts only

Soft silicone rubber

14/2614/36

Moulded inside-out

Unique technology

15/2615/36

The iValve

16/2616/36

exhalation vs inhalation

Atos Freehands: “restart” device after each breath

The iValve: inhalation during speech

17/2617/36

the iValve: three parts only

18/2618/36

the iValve: inhaling

19/2619/36

Optimization

Investigate relation between

•closing flow/opening pressure

and

•cap thickness (different versions)

•number of holes (adjustable)

inhalation holes

20/2620/36

Overview

•iValve workings

•In vitro validation

•In vivo validation

•Conclusions and future development

21/2621/36

simulate exhalation/inhalation in any pattern

Optimization: the Pneumatics Simulator

22/2622/36

closing flow vs cap thickness and holes

mixed effect analysis: relation significant in linear model

Optimization

Presenter
Presentation Notes
Het aantal gaten is significant bij alfa = 0.05 (P < 0.001), de capdikte niet (P = 0.056). De coëfficiënt van holes is afgerond 0.58, wat wil zeggen dat het verschil gemiddeld voor bijplaatsing van twee gaten 1.16 L/s is.

23/2623/36

Optimization

opening pressure vs cap thickness and holes

mixed effect analysis: relation significant in linear model

Presenter
Presentation Notes
Een mixed-effects analyse in R, zie de volgende bladzijde, bevestigt dit beeld. De druk hangt significant (bij alfa = 0.05) af van de cap-dikte in een lineair model (P < 0.001), maar het aantal gaten heeft geen effect (P = 0.64). Toevoeging van de variabele holes aan de random term laat geen verbetering van het model zien. Er kan kritiek uitgeoefend worden op de aanname van lineariteit, maar een model met tweede en derdegraads component van capdikte leverde geen significante verbetering van het model.

24/2624/36

Optimization

Air Flow Resistance Coefficient (ARC2)

0

250

500

750

1000

1250

1500

0 0.5 1 1.5 2 2.5 3 3.5

Flow (L / s)

AR

C (

Pa

.s²/

L²)

iValve (closed)

iValve (open)

Atos Cassette (manual)

Atos Freehands (blue)

Healthy UAR mean range

25/2625/36

Conclusions

The iValve can be optimally adjusted:

•Opening pressure and closing flow are independent

•Opening pressure: 3-6 kPa (cap thickness versions)

•Closing flow: 2-6 L/s (close/open holes)

this is within physiological ranges

•ARC higer than Atos but closer to natural Healthy UAR

26/2626/36

Overview

•iValve workings

•In vitro validation

•In vivo validation

•Conclusions and future development

27/2627/36

In vivo comparitive test TJ van Kalkeren, WAME Schrijver, EB van der

Houwen

Atos FreeHands iValve

Versus

Ntotal

= 14 patients

7pts first Atos then iValve

7pts first iValve then Atos

Presenter
Presentation Notes
Om de nieuwe inhalatieklep in vivo te testen hebben we hem vergeleken met de tegenwoordig veel gebruikte Atos-Provox Free Hands HME exhalatie tracheostomaklep

28/2628/36

In vivo comparitive test TJ van Kalkeren, WAME Schrijver, EB van der

Houwen

Measured variables:

•Pressures and flow

•SPL and fundamental frequency

•Phonation time

•Questionnaire/observations

Hypotheses: iValve provides,

•Louder and longer phonation

•Lower intratracheal pressure and flow

•Continuous speech

interface

flow

Pressure

SPL

Presenter
Presentation Notes
Om de nieuwe inhalatieklep in vivo te testen hebben we hem vergeleken met de tegenwoordig veel gebruikte Atos-Provox Free Hands HME exhalatie tracheostomaklep

29/2629/36

Intratracheal pressure strain on the patch

Soft /aa/ with inhalation valve

-10

0

10

20

30

1 2720 5439 8158 10877 13596 16315 19034 21753 24472 27191 29910

Soft /aa/ iValveP

ress

ure

(cm

H2O

)

Soft /aa/ with exhalation valve

-10

0

10

20

30

40

1 2720 5439 8158 10877 13596 16315 19034 21753 24472 27191 29910

iValve Pmax

iValve Pmin

Soft /aa/ Atos FreeHands

Pre

ssur

e (c

mH

2O)

30/2630/36

Results Questionnaire

•85.7% hands-free speech makes life more easy

•100% would use handsfree if good

•33.3% iValve more difficult than manual occlusion

•57% iValve easier to use than Atos FreeHands

•23.8% generaly (speech, use) preferred the iValve

•33.3% generaly preferred the Atos FreeHands

•81% inhalation iValve still too heavy

•54.5% iValve still too noisy

31/2631/36

Conclusions

+ Whispering possible+ Continuous speech possible (inhaling works)+ Easier to talk + Loudness/pressure/time: no significant difference- Inhalation difficult- Noisy- Too big

The tested iValve is a prototype!

Presenter
Presentation Notes
De conclusies die op basis van dit onderzoek kunnen worden getrokken zijn dat de nieuwe inhalatieklep niet beter of slechter is dan de exhalatieklep, omdat de resultaten die gevonden zijn niet significant zijn. De inhalatieklep is echter wel een prototype waar nog veel aan veranderd kan worden. Dat hij nu al vergelijkbaar is met een bestaande klep wil zeggen dat hij in de toekomst nog wel beter kan worden. Een groot voordeel van de nieuwe klep is dat hij comfortabel is in het gebruik en dat fluisteren mogelijk is. Nadat de klep is aangepast op basis van dit onderzoek dient verder onderzoek te worden gedaan om te kijken of de inhalatieklep beter is geworden.

32/2632/36

Presenter
Presentation Notes
Tot slot nog de aanbeveling van een van de patienten…

33/2633/36

In development

iValve v2.0. Tested and working. •Smaller diameter•Lower ARC at low flows•Less parts•“Standard” HME-filter (cassette)

iValve v2.1. In the making•Even smaller diameter and height

34/2634/36

The iValve prototype works, the patients can’t wait!

Teleac 2010 “Het Academisch Ziekenhuis” National Public Broadcasting For more info: [email protected]

35/2635/36

Lianne Fledderus Árpád Szabó Pablo Serna Sanchez Dionne Haanstra Mayke van Dort Lútzen Kuiper Derk-Jan Alberts Martijn Gijzel Lise de Jonge Agnes Uijttewaal Hanna Pragt Monique Schoeman Arjan Wachtmeester Linda Keijzer Renée Koolschijn Ilona de Jongh Anne Klockow Robert Kroes Nienke Krop Rada Moerman Sara Panahkhahi Steffan Sloot Jan Swartjes Marcel Timmer Freerk Venhuizen Frederik Robijns Felix Wittemann Charissa Roossien Marcel Schouten Bob Giesberts Gábor Koska Jason Pauëlsen Ward Sikkema Rolf Eleveld Tom Oude Hengel

Small part of a TEAM!

Current team:…Tjouwke van KalkerenTom Oude HengelRolf Eleveld…